Genentech Launches Oncology Clinical Trial Diversity Alliance

Genentech

Genentech’s Phase III EMPACTA Study Showed Actemra Reduced the Likelihood of Needing Mechanical Ventilation in Hospitalized Patients With COVID-19 Associated Pneumonia

Genentech

FDA

FDA Accepts Application for Xolair Prefilled Syringe for Self-Administration Across All Indications

Genentech

FDA Approval

FDA Approves Venetoclax for CLL and SLL

U.S. Food & Drug Administration

FDA Approval

Genentech Announces FDA Approval for Venclexta Plus Gazyva for People With Previously Untreated Chronic Lymphocytic Leukemia

Genentech

Clinical Data

New OCREVUS (Ocrelizumab) Data at AAN Demonstrate Significant Reductions in Disease Activity and Disability Progression in Relapsing Multiple Sclerosis

Genentech